期刊文献+

吲达帕胺缓释片的含量测定 被引量:7

Determination of the content of indapamide sustained release tablets
下载PDF
导出
摘要 目的建立高效液相色谱法测定吲达帕胺缓释片含量。方法以十八烷基硅烷键合硅胶为固定相,乙酰苯胺为内标,甲醇-水-冰醋酸(45:55:0.1)为流动相,流速1ml/min,检测波长240nm,测定吲达帕胺缓释片的含量。结果在16.4 ̄57.4μg/ml范围内吲达帕胺呈线性关系,回收率好。结论本法可测定吲达帕胺缓释片的含量。 Objective To establish HPLC method to determine the content of indapamide sustained release tablets. Method The column of C 18 was used and acetanilid sublimed as internal standard, mobile phase composed of methanol-water-acetic acid glacial (45:55:01), flow rate at 1ml/min and determine wavelength at 240nm. Results The method is accurate and show a linear relationship with concentration range from 16.4 to 57.4μg/ml, with an average recovery at 98.44%. Conclusion The method can be used to determine the content of indapamide sustained release tablets.
机构地区 广东药学院
出处 《药品评价》 CAS 2006年第1期60-62,共3页 Drug Evaluation
关键词 吲达帕胺 色谱法 高效液相 含量均匀度 缓解剂 Indapamide chrmatograply,high performance liquid content equitability depot preparations
  • 相关文献

参考文献2

二级参考文献9

  • 1[1]MacMahon S. Rodgers A. et al The effects of blood pressure reduction in older patients: an overview of five randomized controlled trials in elderly hypertensives. Clin EXP Hypertens,1993;15:967~78
  • 2[2]MRC Working Party: Medical Research Council trial of treatment of treatment of hypertension in older adults: principal results. Br Med J,1992;148:1023
  • 3[3]Amery A, BirkenhEager WH, Bulpiitt C J, Dollery CT, et al. WPHE The European Working Party on High blood pressure in the Elderly .Am J Med, 1991 ;90(Suppl.3A):3A- 1 S-64S and addenda.
  • 4[4]Donald Weidler, Nadeer S, Jallad, Charles Curry, et al. Efficacious Response with lower Dose Indapamide Therapy in the treatment of Elderly Patients with Mild to Moderate Hypertension. J Clin Pharmacol, 1995;35:45~51.
  • 5[5]Asmar R, Guez D, Malbezin M, et al. Therapeutic benefit of a low dose ofjndapamide :results of a double-blind against placebo European controlled Study [in French]. Arch Mai Coeur Vaiss, 1995; 88:1083~1087.
  • 6[6]Anbrosioni E, Safar M, Degaute JP, et al. Low-dose antihypertensive therapy with 1.Smg sustained-release indapamide: results of randomized double-blind controlled studies. J Hypertens, 1998; 16:1677~1684.
  • 7[7]Peter A, Carey, BSc, Desmond J, Sheridan, et al. Effect of Indapamide on Left Ventricular Hypertrophy in Hypertension: A Meta-Analysis. Am J Cardiol, 1996;77:17B~ 19B.
  • 8[8]Andrejal M, Genes N, Vaur L, Poncelet P, et al. Electronic pillboxes in the evaluation of antihypertensive treatment compliance:comparison of once daily versus twice daily regimen. Am J Hypertens,2000(Feb); 13:184~190.
  • 9[9]Madkour H, Gadallah M, Riveline B. et al. Indapamide is superior to thiazide in the preservation of renal function in patients with renal insufficiency and systemic hypertension. Am J Cardiol, 1996(Feb);22;77:23b~25b.

共引文献22

同被引文献22

引证文献7

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部